MICHAEL S. WEISS - 13 Dec 2024 Form 4 Insider Report for Checkpoint Therapeutics, Inc. (CKPT)

Role
Director
Signature
/s/ James F. Oliviero, Attorney-in-Fact
Issuer symbol
CKPT
Transactions as of
13 Dec 2024
Net transactions value
$0
Form type
4
Filing time
17 Dec 2024, 21:33:54 UTC
Previous filing
16 May 2024
Next filing
03 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CKPT COMMON STOCK Award $0 +12,638 +11% $0.000000 124,812 13 Dec 2024 See Note 3 F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents previously-granted performance-based award that became vested upon achievement of a corporate milestone on December 13, 2024.
F2 Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Weiss's continued service on the board.
F3 The shares are held by Hawkins BioVentures, LLC, of which Mr. Weiss is the sole member.